Safety guidelines for nonsurgical facial procedures during COVID-19 outbreak.
Betacoronavirus
/ pathogenicity
COVID-19
Consensus
Coronavirus Infections
/ epidemiology
Cosmetic Techniques
/ standards
Dermatology
/ standards
Esthetics
Face
Female
Focus Groups
Health Personnel
/ standards
Humans
Infection Control
/ standards
Infectious Disease Transmission, Patient-to-Professional
/ prevention & control
Infectious Disease Transmission, Professional-to-Patient
/ prevention & control
Male
Pandemics
/ prevention & control
Pneumonia, Viral
/ epidemiology
Practice Guidelines as Topic
Rejuvenation
SARS-CoV-2
COVID-19
aesthetic clinic
aesthetic medicine
consensus guidelines
coronavirus
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
received:
19
05
2020
revised:
28
05
2020
accepted:
28
05
2020
pubmed:
9
6
2020
medline:
29
7
2020
entrez:
8
6
2020
Statut:
ppublish
Résumé
The novel coronavirus (COVID-19) pandemic is expected to last for an extended time, making strict safety precautions for office procedures unavoidable. The lockdown is going to be lifted in many areas, and strict guidelines detailing the infection control measures for aesthetic clinics are going to be of particular importance. A virtual meeting was conducted with the members (n = 12) of the European Academy of Facial Plastic Surgery Focus Group to outline the safety protocol for the nonsurgical facial aesthetic procedures for aesthetic practices in order to protect the clinic staff and the patients from SARS-CoV-2 infection. The data analysis was undertaken by thematic and iterative approach. Consensus guidelines for nonsurgical facial aesthetic procedures based on current knowledge are provided for three levels: precautions before visiting the clinic, precautions during the clinic visit, and precautions after the clinic visit. Sound infection control measures are mandatory for nonsurgical aesthetic practices all around the world. These may vary from country to country, but this logical approach can be customized according to the respective country laws and guidelines.
Sections du résumé
BACKGROUND
BACKGROUND
The novel coronavirus (COVID-19) pandemic is expected to last for an extended time, making strict safety precautions for office procedures unavoidable. The lockdown is going to be lifted in many areas, and strict guidelines detailing the infection control measures for aesthetic clinics are going to be of particular importance.
METHODS
METHODS
A virtual meeting was conducted with the members (n = 12) of the European Academy of Facial Plastic Surgery Focus Group to outline the safety protocol for the nonsurgical facial aesthetic procedures for aesthetic practices in order to protect the clinic staff and the patients from SARS-CoV-2 infection. The data analysis was undertaken by thematic and iterative approach.
RESULTS
RESULTS
Consensus guidelines for nonsurgical facial aesthetic procedures based on current knowledge are provided for three levels: precautions before visiting the clinic, precautions during the clinic visit, and precautions after the clinic visit.
CONCLUSIONS
CONCLUSIONS
Sound infection control measures are mandatory for nonsurgical aesthetic practices all around the world. These may vary from country to country, but this logical approach can be customized according to the respective country laws and guidelines.
Identifiants
pubmed: 32506541
doi: 10.1111/jocd.13530
pmc: PMC7300825
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1829-1837Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2020 Wiley Periodicals, LLC.
Références
Ecotoxicol Environ Saf. 2020 Jul 15;198:110598
pubmed: 32335416
J Dent Res. 2020 May;99(5):481-487
pubmed: 32162995
New Sci. 2020 Apr 11;246(3277):10-12
pubmed: 32372802
Med J Armed Forces India. 2020 Apr;76(2):128-131
pubmed: 32292234
Med Microbiol Immunol. 2005 Jan;194(1-2):1-6
pubmed: 15118911
J Infect. 2020 Jul;81(1):e67-e68
pubmed: 32251688
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
Anesth Analg. 2020 Jul;131(1):97-101
pubmed: 32541583
J Am Acad Dermatol. 2020 Jul;83(1):e29-e30
pubmed: 32283242
N Engl J Med. 2020 Apr 16;382(16):1564-1567
pubmed: 32182409
J Am Coll Radiol. 2020 Jun;17(6):710-716
pubmed: 32208140
BMC Med. 2020 Feb 28;18(1):57
pubmed: 32106852
BMC Public Health. 2018 Apr 18;18(1):518
pubmed: 29669545
J Cosmet Dermatol. 2020 Aug;19(8):1829-1837
pubmed: 32506541
Water Res. 2015 Mar 1;70:27-37
pubmed: 25506761
J Thorac Dis. 2018 Jul;10(Suppl 19):S2295-S2304
pubmed: 30116608
Dermatol Ther. 2020 Jul;33(4):e13310
pubmed: 32170800
J Eval Clin Pract. 2001 Feb;7(1):65-70
pubmed: 11240840
Nat Med. 2020 Apr;26(4):463-464
pubmed: 32284619
Viruses. 2012 Nov 12;4(11):3044-68
pubmed: 23202515
Fam Pract. 2002 Jun;19(3):285-9
pubmed: 11978720
Cochrane Database Syst Rev. 2020 Apr 21;4:CD013582
pubmed: 32315451
Int J Antimicrob Agents. 2020 Mar;55(3):105924
pubmed: 32081636
J Am Acad Dermatol. 2020 Apr;82(4):1034
pubmed: 32081700
N Engl J Med. 2020 Mar 19;382(12):1177-1179
pubmed: 32074444
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Nat Med. 2020 May;26(5):643-644
pubmed: 32405055
J Am Acad Dermatol. 2020 Jun;82(6):e231-e232
pubmed: 32278795
J Eur Acad Dermatol Venereol. 2020 May;34(5):e210-e211
pubmed: 32201983